NIR and Raman Spectroscopy Market - Global Forecast to 2030

By 2030, the NIR and Raman spectroscopy market is anticipated to reach USD 3,152.22 million, growing at a CAGR of 11.72% from 2022 to 2030. A chronic disease is one that lasts over an extended period. The prevalence of chronic diseases among adults worldwide in 2019 was over 60%, according to the Centers for Disease Control and Prevention, and it is apparently much greater among the elderly. A quick, easy, portable, noninvasive, and affordable technique for functional diagnosis and treatment monitoring of cancer and other chronic diseases is near-infrared (NIR) spectroscopy. Using either oxy-hemoglobin or deoxyhemoglobin, lipid or water bands, or both, it is based on variations in endogenous chromophores between cancer and normal tissues.

The market is expanding because of the rise in chronic disease prevalence, the rise in demand for Process Analytical Technology (PAT) instruments, and improvements in NIR and Raman spectroscopy technology. The market will also have room to grow in the future because of the rise in interest in cloud-based spectroscopy. The absence of skilled and experienced professionals could, however, limit the market's growth over the entire predicted duration.

Market Segmentation

Global NIR and Raman Spectroscopy Market are classified based on Product, application, and region.

In terms of product, the market is divided into Near-infrared Spectroscopy and Raman spectroscopy. Near-infrared Spectroscopy is further classified into Scanning, Fourier-transform, and Filter or AOTF whereas Raman Spectroscopy is subdivided into Micro-Raman Spectroscopy, Probe-based Raman Spectroscopy, and FT-Raman Spectroscopy. The Application, segment includes Pharmaceutical Applications, Biotechnology & Biopharmaceutical Applications, Food & Beverage Testing, Environment Testing, Academic Research, and Others.

Regional Analysis

Geographically, the worldwide NIR and Raman spectroscopy market has been portioned, into North America, Europe, Asia Pacific, and the Rest of the World.

The NIR and Raman spectroscopy market development in North America is credited to the high pervasiveness of different ongoing sicknesses, including disease, diabetes, and cardiovascular problems, and rising medical services consumption. The American Malignant Growth Society assessed that 1.9 million new disease cases would be analyzed and 609,360 disease-related passings in 2022 in the US. Essentially, as per the information distributed by World Wellbeing Association (WHO), in 2020, 2,281,685 new disease cases were enrolled in the US 2020. Then again, Canada represented 274,364 new malignant growth cases in 2020. Raman and NIR spectroscopy is generally utilized in Cycle Logical Innovation (PAT) applications as these methods are non-horrendous scientific strategies that can break down materials in their present status without test planning (without dissolving the materials).

The rising pervasiveness of ongoing sicknesses, the rising geriatric populace, and NIR and Raman spectroscopy mechanical progressions drive NIR and Raman spectroscopy market development. An article distributed by Populace Reference Agency (PRB) in 2019 expressed that Asia and Europe are the home to the world's most established populaces, matured 65 and above. Japan (28%) enlisted the most elevated geriatric populace, trailed by Italy (23%), Finland, Portugal, Greece (22%), and China (12%).

Major Players

The prominent players in the global NIR and Raman spectroscopy market are Bruker (US), Agilent Technologies, Inc. (US), JASCO (Spain), Thermo Fisher Scientific Inc. (US), Shimadzu Corporation (Japan), Danaher (US), Merck KGaA (Germany), PerkinElmer Inc. (US), ABB (Sweden), and Horiba, ltd (Japan).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Product Code: MRFR/HC/9420-CR

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW
- 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
- 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
- 4.2.2 GROWING DEMAND FOR PROCESS ANALYTICAL TECHNOLOGY (PAT) TOOLS
- 4.2.3 TECHNOLOGICAL ADVANCEMENTS IN NIR AND RAMAN SPECTROSCOPY
4.3 RESTRAINTS
- 4.3.1 SHORTAGE OF SKILLED AND EXPERIENCED PROFESSIONALS
4.4 OPPORTUNITY
- 4.4.1 RISING DEMAND FOR CLOUD-BASED SPECTROSCOPY

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON PRICING
- 5.3.3 IMPACT ON KEY PLAYERS
5.4 NIR AND RAMAN SPECTROSCOPY AS FOR PROCESS ANALYTICAL TECHNOLOGY (PAT) TOOLS

6 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET BY PRODUCT

6.1 OVERVIEW
6.2 NEAR-INFRARED SPECTROSCOPY
- 6.2.1 SCANNING
- 6.2.2 FOURIER-TRANSFORM
- 6.2.3 FILTER OR AOTF
6.3 RAMAN SPECTROSCOPY
- 6.3.1 MICRO-RAMAN SPECTROSCOPY
- 6.3.2 PROBE-BASED RAMAN SPECTROSCOPY
- 6.3.3 FT-RAMAN SPECTROSCOPY
- 6.3.4 OTHERS

7 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET BY APPLICATION

7.1 OVERVIEW
7.2 PHARMACEUTICAL APPLICATIONS
7.3 BIOTECHNOLOGY & BIOPHARMACEUTICAL APPLICATIONS
7.4 FOOD & BEVERAGE TESTING
7.5 ENVIRONMENT TESTING
7.6 ACADEMIC RESEARCH
7.7 OTHERS

8 GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 AUSTRALIA
- 8.4.5 SOUTH KOREA
- 8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
- 8.5.1 MIDDLE EAST
- 8.5.2 AFRICA
- 8.5.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL NIR AND RAMAN SPECTROSCOPY MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
- 9.6.2 PARTNERSHIP/COLLABORATION
- 9.6.3 MERGERS & ACQUISITIONS
9.7 MAJOR PLAYERS SALES ANALYSIS
- 9.7.1 SALES & OPERATING INCOME
9.8 MAJOR PLAYERS R&D ANALYSIS
- 9.8.1 R&D EXPENDITURE

10 COMPANY PROFILES

10.1 THERMO FISHER SCIENTIFIC INC.
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL ANALYSIS
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 BRUKER
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 KEY STRATEGIES
10.3 PERKINELMER INC.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS 0FFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 AGILENT TECHNOLOGIES, INC.
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
10.5 JASCO
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL ANALYSIS
- 10.5.3 PRODUCTS/SERVICES OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 SHIMADZU CORPORATION
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
10.7 DANAHER
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 MERCK KGAA
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
10.9 ABB
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 HORIBA, LTD
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES
11.2 RELATED REPORTS